LeMaitre Vascular Net Profit Margin 2010-2024 | LMAT
LeMaitre Vascular net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| LeMaitre Vascular Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $0.22B | $0.04B | 20.00% |
| 2024-09-30 | $0.21B | $0.04B | 19.25% |
| 2024-06-30 | $0.21B | $0.04B | 18.54% |
| 2024-03-31 | $0.20B | $0.03B | 17.09% |
| 2023-12-31 | $0.19B | $0.03B | 15.54% |
| 2023-09-30 | $0.19B | $0.03B | 15.14% |
| 2023-06-30 | $0.18B | $0.03B | 14.12% |
| 2023-03-31 | $0.17B | $0.02B | 12.43% |
| 2022-12-31 | $0.16B | $0.02B | 12.96% |
| 2022-09-30 | $0.16B | $0.02B | 13.04% |
| 2022-06-30 | $0.16B | $0.02B | 14.38% |
| 2022-03-31 | $0.16B | $0.03B | 16.98% |
| 2021-12-31 | $0.16B | $0.03B | 17.42% |
| 2021-09-30 | $0.15B | $0.03B | 18.30% |
| 2021-06-30 | $0.15B | $0.03B | 19.21% |
| 2021-03-31 | $0.14B | $0.03B | 18.52% |
| 2020-12-31 | $0.13B | $0.02B | 16.92% |
| 2020-09-30 | $0.12B | $0.02B | 16.39% |
| 2020-06-30 | $0.12B | $0.02B | 14.78% |
| 2020-03-31 | $0.12B | $0.02B | 15.13% |
| 2019-12-31 | $0.12B | $0.02B | 16.38% |
| 2019-09-30 | $0.11B | $0.02B | 17.54% |
| 2019-06-30 | $0.11B | $0.02B | 17.43% |
| 2019-03-31 | $0.11B | $0.02B | 21.50% |
| 2018-12-31 | $0.11B | $0.02B | 21.90% |
| 2018-09-30 | $0.10B | $0.02B | 20.39% |
| 2018-06-30 | $0.10B | $0.02B | 21.15% |
| 2018-03-31 | $0.10B | $0.02B | 17.48% |
| 2017-12-31 | $0.10B | $0.02B | 16.83% |
| 2017-09-30 | $0.10B | $0.02B | 16.33% |
| 2017-06-30 | $0.10B | $0.01B | 14.58% |
| 2017-03-31 | $0.09B | $0.01B | 13.04% |
| 2016-12-31 | $0.09B | $0.01B | 12.50% |
| 2016-09-30 | $0.09B | $0.01B | 12.94% |
| 2016-06-30 | $0.08B | $0.01B | 12.35% |
| 2016-03-31 | $0.08B | $0.01B | 11.39% |
| 2015-12-31 | $0.08B | $0.01B | 10.26% |
| 2015-09-30 | $0.08B | $0.01B | 9.09% |
| 2015-06-30 | $0.08B | $0.01B | 7.89% |
| 2015-03-31 | $0.07B | $0.01B | 6.76% |
| 2014-12-31 | $0.07B | $0.00B | 5.56% |
| 2014-09-30 | $0.07B | $0.00B | 4.23% |
| 2014-06-30 | $0.07B | $0.00B | 4.41% |
| 2014-03-31 | $0.07B | $0.00B | 4.55% |
| 2013-12-31 | $0.06B | $0.00B | 6.25% |
| 2013-09-30 | $0.06B | $0.00B | 6.56% |
| 2013-06-30 | $0.06B | $0.00B | 6.67% |
| 2013-03-31 | $0.06B | $0.00B | 6.90% |
| 2012-12-31 | $0.06B | $0.00B | 5.26% |
| 2012-09-30 | $0.06B | $0.00B | 3.64% |
| 2012-06-30 | $0.06B | $0.00B | 3.57% |
| 2012-03-31 | $0.06B | $0.00B | 3.51% |
| 2011-12-31 | $0.06B | $0.00B | 3.45% |
| 2011-09-30 | $0.06B | $0.00B | 6.78% |
| 2011-06-30 | $0.06B | $0.01B | 8.62% |
| 2011-03-31 | $0.06B | $0.01B | 10.53% |
| 2010-12-31 | $0.06B | $0.01B | 12.50% |
| 2010-09-30 | $0.06B | $0.01B | 10.71% |
| 2010-06-30 | $0.06B | $0.01B | 9.09% |
| 2010-03-31 | $0.05B | $0.00B | 7.41% |
| 2009-12-31 | $0.05B | $0.00B | 1.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.050B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.763B | 27.35 |
| Boston Scientific (BSX) | United States | $152.152B | 38.10 |
| Stryker (SYK) | United States | $142.721B | 30.67 |
| EssilorLuxottica (ESLOY) | France | $133.556B | 0.00 |
| Medtronic (MDT) | Ireland | $108.708B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.613B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.796B | 26.03 |
| ResMed (RMD) | United States | $34.691B | 26.06 |
| GE HealthCare Technologies (GEHC) | United States | $32.200B | 15.29 |
| Agilent Technologies (A) | United States | $30.677B | 20.26 |
| Terumo (TRUMY) | Japan | $28.397B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.827B | 17.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.388B | 12.88 |
| Insulet (PODD) | United States | $17.717B | 75.76 |
| Baxter (BAX) | United States | $15.988B | 11.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.272B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.145B | 17.57 |
| Bio-Rad Laboratories (BIO) | United States | $6.837B | 23.67 |
| Prestige Consumer Healthcare (PBH) | United States | $4.024B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.362B | 28.64 |
| Haemonetics (HAE) | United States | $3.166B | 14.90 |
| Envista Holdings (NVST) | United States | $2.725B | 22.03 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 18.72 |
| QuidelOrtho (QDEL) | United States | $1.875B | 15.70 |
| AtriCure (ATRC) | United States | $1.480B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.401B | 22.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.235B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.05 |
| BioLife Solutions (BLFS) | United States | $1.145B | 0.00 |
| Neogen (NEOG) | United States | $1.096B | 14.03 |
| InMode (INMD) | Israel | $0.981B | 8.98 |
| Phibro Animal Health (PAHC) | United States | $0.754B | 11.56 |
| Evolus (EOLS) | United States | $0.735B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.713B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.580B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.545B | 4.64 |
| Valneva SE (VALN) | France | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.479B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Surmodics (SRDX) | United States | $0.400B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.343B | 14.86 |
| Verano Holdings (VRNOF) | United States | $0.323B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 25.25 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Canopy Growth (CGC) | Canada | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.252B | 15.10 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Utah Medical Products (UTMD) | United States | $0.170B | 13.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.00 |
| Organigram Global (OGI) | Canada | $0.146B | 0.00 |
| Jin Medical (ZJYL) | China | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Agape ATP (ATPC) | $0.115B | 0.00 | |
| Exagen (XGN) | United States | $0.112B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.039B | 0.00 |
| Safety Shot (SHOT) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 54.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |